NCT05067439 A Study to Estimate the Effect of Multiple Dose Abrocitinib on Caffeine, Efavirenz, and Omeprazole in Healthy Participants Status COMPLETED Phase PHASE1
NCT05064839 Imaging for the Evaluation of Transthyretin Cardiac Amyloidosis Prevalence of Patients Over 65 Hospitalized in Cardiology Wards (the IMPACT Study) Status COMPLETED Phase PHASE3
NCT05064800 PF-07321332/Ritonavir and Ritonavir on Dabigatran Study in Healthy Participants Status COMPLETED Phase PHASE1
NCT05064332 A Study To Estimate The Effect of PF-06650833 On The Pharmacokinetics (PK) of Oral Contraceptive (OC) Status COMPLETED Phase PHASE1
NCT05061537 Study of PF-07263689 in Participants With Selected Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT05061446 Etrasimod Dose-Ranging Versus Placebo as Induction Therapy Study in Adult Japanese Subjects With Moderately to Severely Active Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT05061277 Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Recifercept in Healthy Chinese Participants Status WITHDRAWN Phase PHASE1
NCT05059522 Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05052697 A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against Influenza Status COMPLETED Phase PHASE1/PHASE2
NCT05052307 A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine in Brazil Status COMPLETED Phase N/A
NCT05050682 Study to Investigate the Mass Balance, Metabolism, and Excretion of [14C]-PF-07304814 in Healthy Participants Status COMPLETED Phase PHASE1
NCT05047601 A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection Status COMPLETED Phase PHASE2/PHASE3
NCT05046613 Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant Status RECRUITING Phase N/A
NCT05043506 European Treatment Patterns and Outcomes Associated With First-Line CDK4/6 Inhibition and Hormonal Therapies Status COMPLETED Phase N/A
NCT05040295 A Single Dose Study To Test Two Pediatric Forms Of Ritlecitinib Compared With Adult Ritlecitinib In Healthy Adults Status COMPLETED Phase PHASE1
NCT05038982 Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin Status COMPLETED Phase PHASE2
NCT05038228 High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in France Status COMPLETED Phase N/A
NCT05037409 Investigation of Safety, Tolerability, Immunogenicity and Pharmacokinetics of Single-Dose of PF-06823859 in Japanese Healthy Participants Status COMPLETED Phase PHASE1
NCT05036512 A Study to Evaluate GBT021601 in Single and Multiple Doses in Healthy Participants Status COMPLETED Phase PHASE1
NCT05035212 Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults. Status ACTIVE_NOT_RECRUITING Phase PHASE3